Geng Hu
胡庚
elsewhere's corpus does not cover Geng Hu as a subject — no retrieved material is actually about this person. The name appears only as a background mention in coverage of other entities (for example, a 2024 暗涌Waves piece on an under-the-radar FA and a 2025 暗涌Waves article on investors of Ning Wang, Xingxing Wang, and Junjie Zhang ), which does not establish who Geng Hu is, their role, or any biographical facts.
AI-generated — may contain errors, please verify.
Coverage
Gaorong Ventures in Conversation with Hejeya and Qitan Tech: How Innovative Medical Devices "Cross the Razor's Edge"
"When you meet a mountain, you cut a path through it; when you meet a river, you build a bridge across it."
高榕创投·Qitan Tech Closes RMB 700 Million Series C Round to Advance Commercialization of Domestic Nanopore Sequencing Technology
Breaking Through the "Mass-Production No-Man's-Land" of Domestic Nanopore Sequencing
高榕创投·Qitan Tech Raises Over 400 Million Yuan in Series B, Leading the Nanopore Gene Sequencer Race
China's first fully self-developed nanopore gene sequencer is slated for mass production later this year.
高榕创投·Leading nanopore gene sequencing company **Qitan Technology** has raised over RMB 100 million in funding, led by Gaorong Ventures.
Focused on the independent R&D of nanopore gene sequencers, dedicated to making gene sequencing technology accessible to every household.
高榕创投·
